@article{670b84cef5694e50a1c34da804ff1fc2,
title = "Soft, Dynamic Hydrogel Confinement Improves Kidney Organoid Lumen Morphology and Reduces Epithelial-Mesenchymal Transition in Culture",
abstract = "Pluripotent stem cell-derived kidney organoids offer a promising solution to renal failure, yet current organoid protocols often lead to off-target cells and phenotypic alterations, preventing maturity. Here, various dynamic hydrogel architectures are created, conferring a controlled and biomimetic environment for organoid encapsulation. How hydrogel stiffness and stress relaxation affect renal phenotype and undesired fibrotic markers are investigated. The authors observe that stiff hydrogel encapsulation leads to an absence of certain renal cell types and signs of an epithelial-mesenchymal transition (EMT), whereas encapsulation in soft, stress-relaxing hydrogels leads to all major renal segments, fewer fibrosis or EMT associated proteins, apical proximal tubule polarization, and primary cilia formation, representing a significant improvement over current approaches to culture kidney organoids. The findings show that engineering hydrogel mechanics and dynamics have a decided benefit for organoid culture. These structure-property-function relationships can enable the rational design of materials, bringing us closer to functional engraftments and disease-modeling applications.",
keywords = "Epithelial-Mesenchymal Transition, Hydrogels, Kidney, Organoids, Pluripotent Stem Cells, epithelial–mesenchymal transition, dynamic hydrogels, primary cilia, kidney organoids, viscoelastic",
author = "Ruiter, {Floor A A} and Morgan, {Francis L C} and Nadia Roumans and Anika Schumacher and Slaats, {Gisela G} and Lorenzo Moroni and LaPointe, {Vanessa L S} and Baker, {Matthew B}",
note = "Funding Information: This work is supported by the partners of Regenerative Medicine Crossing Borders (RegMed XB), a public‐private partnership that uses regenerative medicine strategies to cure common chronic diseases. It is financed by the Dutch Ministry of Economic Affairs by means of the PPP Allowance made available by the Top Sector Life Sciences & Health to stimulate public‐private partnerships. MBB and VLSL would like to acknowledge funding from the Dutch Province of Limburg; FLCM, LM, and MBB would like to thank funding from NWO under project agreement 731.016.202 “DynAM”. The authors also would like to thank Christian Freund (hiPSC core facility, LUMC, Leiden, the Netherlands) for supplying the hiPSC line (LUMC0072iCTRL01) used in this study, and Nathalie Groen for conducting the scRNA sequencing analyses. Funding Information: This work is supported by the partners of Regenerative Medicine Crossing Borders (RegMed XB), a public-private partnership that uses regenerative medicine strategies to cure common chronic diseases. It is financed by the Dutch Ministry of Economic Affairs by means of the PPP Allowance made available by the Top Sector Life Sciences & Health to stimulate public-private partnerships. MBB and VLSL would like to acknowledge funding from the Dutch Province of Limburg; FLCM, LM, and MBB would like to thank funding from NWO under project agreement 731.016.202 “DynAM”. The authors also would like to thank Christian Freund (hiPSC core facility, LUMC, Leiden, the Netherlands) for supplying the hiPSC line (LUMC0072iCTRL01) used in this study, and Nathalie Groen for conducting the scRNA sequencing analyses. Publisher Copyright: {\textcopyright} 2022 The Authors. Advanced Science published by Wiley-VCH GmbH.",
year = "2022",
month = jul,
day = "15",
doi = "10.1002/advs.202200543",
language = "English",
volume = "9",
pages = "e2200543",
journal = "Advanced Science",
publisher = "Wiley-VCH Verlag",
number = "20",
}